Cargando…
Genetic association with overall survival of taxane-treated lung cancer patients - a genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study
BACKGROUND: Taxane is one of the first line treatments of lung cancer. In order to identify novel single nucleotide polymorphisms (SNPs) that might contribute to taxane response, we performed a genome-wide association study (GWAS) for two taxanes, paclitaxel and docetaxel, using 276 lymphoblastoid c...
Autores principales: | Niu, Nifang, Schaid, Daniel J, Abo, Ryan P, Kalari, Krishna, Fridley, Brooke L, Feng, Qiping, Jenkins, Gregory, Batzler, Anthony, Brisbin, Abra G, Cunningham, Julie M, Li, Liang, Sun, Zhifu, Yang, Ping, Wang, Liewei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573965/ https://www.ncbi.nlm.nih.gov/pubmed/23006423 http://dx.doi.org/10.1186/1471-2407-12-422 |
Ejemplares similares
-
Genome-wide association study for biomarker identification of Rapamycin and Everolimus using a lymphoblastoid cell line system
por: Jiang, Jing, et al.
Publicado: (2013) -
Discovery of genetic biomarkers contributing to variation in drug response of cytidine analogues using human lymphoblastoid cell lines
por: Li, Liang, et al.
Publicado: (2014) -
Identification of genetic variants or genes that are associated with Homoharringtonine (HHT) response through a genome-wide association study in human lymphoblastoid cell lines (LCLs)
por: Tong, Yin, et al.
Publicado: (2015) -
Localization of Association Signal from Risk and Protective Variants in Sequencing Studies
por: Brisbin, Abra, et al.
Publicado: (2012) -
Gemcitabine and Arabinosylcytosin Pharmacogenomics: Genome-Wide Association and Drug Response Biomarkers
por: Li, Liang, et al.
Publicado: (2009)